Hikma Pharmaceuticals PLC
HKMPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6,167,981 | $5,351,015 | $5,650,000 | $5,160,739 |
| - Cash | $236,000 | $188,000 | $236,000 | $205,000 |
| + Debt | $1,558,000 | $1,306,000 | $1,276,000 | $1,191,000 |
| Enterprise Value | $7,489,981 | $6,469,015 | $6,690,000 | $6,146,739 |
| Revenue | $1,658,000 | $1,558,000 | $1,569,000 | $1,448,000 |
| % Growth | 6.4% | -0.7% | 8.4% | – |
| Gross Profit | $725,000 | $659,000 | $756,000 | $692,000 |
| % Margin | 43.7% | 42.3% | 48.2% | 47.8% |
| EBITDA | $476,000 | $288,000 | $499,000 | $345,000 |
| % Margin | 28.7% | 18.5% | 31.8% | 23.8% |
| Net Income | $238,000 | $133,000 | $226,000 | $59,000 |
| % Margin | 14.4% | 8.5% | 14.4% | 4.1% |
| EPS Diluted | 1.07 | 0.6 | 1.01 | 0.27 |
| % Growth | 78.3% | -40.6% | 274.1% | – |
| Operating Cash Flow | $161,000 | $366,000 | $198,000 | $386,000 |
| Capital Expenditures | -$68,000 | -$96,000 | -$69,000 | -$85,000 |
| Free Cash Flow | $93,000 | $270,000 | $129,000 | $301,000 |